High B-Cell Depletion Succeeds in Lupus Nephritis

(MedPage Today) -- The B-cell depleting monoclonal antibody obinutuzumab (Gazyva) showed efficacy through 2 years for patients with lupus nephritis, a severe complication of systemic lupus erythematosus that affects some 45% of lupus patients and...